Evidence map›Paper›PMID 40328765›Full record

ArticleNature communications2025

A highly conserved neuronal microexon in DAAM1 controls actin dynamics, RHOA/ROCK signaling, and memory formation.

Patryk Poliński, Marta Miret Cuesta, Alfonsa Zamora-Moratalla, Federica Mantica, Gerard Cantero-Recasens, Carlotta Viana, Miguel Sabariego-Navarro, Davide Normanno, Luis P Iñiguez, Cruz Morenilla-Palao and 22 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Patryk PolińskiCentre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain. patrykpolinski@gmail.com.ORCID http://orcid.org/0000-0002-1733-7983
Marta Miret Cuesta *Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.ORCID http://orcid.org/0000-0002-1083-5904
Alfonsa Zamora-Moratalla *Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.
Federica ManticaCentre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.
Gerard Cantero-RecasensCentre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.ORCID http://orcid.org/0000-0001-6452-782X
Carlotta VianaCentre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.
Miguel Sabariego-NavarroCentre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.
Davide NormannoCentre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.ORCID http://orcid.org/0000-0003-4740-5542
Luis P IñiguezCentre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.ORCID http://orcid.org/0000-0002-1470-9024
Cruz Morenilla-PalaoInstituto de Neurociencias (CSIC-UMH), Alicante, Spain.
Patricia OrdoñoInstituto de Neurociencias (CSIC-UMH), Alicante, Spain.ORCID http://orcid.org/0000-0002-4140-7750
Sophie BonnalCentre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.
Jonathan D EllisDonnelly Centre, University of Toronto, Toronto, Canada.
Raúl Gómez-RieraCentre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.ORCID http://orcid.org/0000-0003-4197-180X
Hugo Fanlo-UcarUniversitat Pompeu Fabra, Barcelona, Spain.ORCID http://orcid.org/0000-0001-7420-6501
Dominic S YapCentre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.
María Martínez De LagránCentre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.ORCID http://orcid.org/0000-0002-0836-6491
Álvaro Fernández-BlancoCentre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.
Cristina Rodríguez-MarinCentre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.
Jon PermanyerCentre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.
Orsolya FölszCentre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.
Eduardo Dominguez-SalaCentre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.
Cesar SierraCentre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.
Diana LegutkoNencki Institute of Experimental Biology, BRAINCITY, Warsaw, Poland.ORCID http://orcid.org/0000-0002-9463-640X
José WojnackiCentre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.
Juan Luis Musoles LleoCentre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.ORCID http://orcid.org/0000-0002-2474-0009
Maria Pia CosmaCentre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.ORCID http://orcid.org/0000-0003-4207-5097
Francisco José MuñozUniversitat Pompeu Fabra, Barcelona, Spain.
Benjamin J BlencoweDonnelly Centre, University of Toronto, Toronto, Canada.ORCID http://orcid.org/0000-0002-4461-0340
Eloisa HerreraInstituto de Neurociencias (CSIC-UMH), Alicante, Spain.ORCID http://orcid.org/0000-0001-9525-5441
Mara DierssenCentre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain. mara.dierssen@crg.eu.
Manuel IrimiaCentre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain. mirimia@gmail.com.ORCID http://orcid.org/0000-0002-2179-2567

Funding

EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 101002275
6 · The paper itself

Abstract

Actin cytoskeleton dynamics is essential for proper nervous system development and function. A conserved set of neuronal-specific microexons influences multiple aspects of neurobiology; however, their roles in regulating the actin cytoskeleton are unknown. Here, we study a microexon in DAAM1, a formin-homology-2 (FH2) domain protein involved in actin reorganization. Microexon inclusion extends the linker region of the DAAM1 FH2 domain, altering actin polymerization. Genomic deletion of the microexon leads to neuritogenesis defects and increased calcium influx in differentiated neurons. Mice with this deletion exhibit postsynaptic defects, fewer immature dendritic spines, impaired long-term potentiation, and deficits in memory formation. These phenotypes are associated with increased RHOA/ROCK signaling, which regulates actin-cytoskeleton dynamics, and are partially rescued by treatment with a ROCK inhibitor. This study highlights the role of a conserved neuronal microexon in regulating actin dynamics and cognitive functioning.

Indexed as

ActinsMemoryMicrofilament ProteinsNeuronsrhoA GTP-Binding Proteinrho-Associated KinasesActin CytoskeletonAnimalsDendritic SpinesExonsLong-Term PotentiationMaleMiceMice, KnockoutNeurogenesisrho GTP-Binding ProteinsActinsDaam1 protein, mouseMicrofilament ProteinsrhoA GTP-Binding ProteinRhoA protein, mouserho-Associated Kinasesrho GTP-Binding Proteins

Identifiers

PMID40328765
PMCPMC12056172

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.